Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 31, 2024	Oct. 31, 2023
Current assets:
Cash, cash equivalents and restricted cash	$ 3,253	$ 3,232
Accounts receivable, net of allowance for credit losses of $83 and $93, respectively	5,117	4,237
Inventory	7,720	6,862
Other current assets	4,670	3,646
Total current assets	20,760	17,977
Property, plant and equipment, net	2,914	2,827
Goodwill	8,627	8,591
Other non-current assets	7,608	7,609
Total assets	39,909	37,004
Current liabilities:
Notes payable and short-term borrowings	1,406	230
Accounts payable	16,903	14,046
Other current liabilities	10,378	10,212
Total current liabilities	28,687	24,488
Long-term debt	8,263	9,254
Other non-current liabilities	4,282	4,331
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01par value (9,600 shares authorized; 939 and 989 shares issued and outstanding as of October 31, 2024, and 2023, respectively)	9	10
Additional paid-in capital	1,778	1,505
Accumulated deficit	(2,676)	(2,361)
Accumulated other comprehensive loss	(434)	(223)
Total stockholders’ deficit	(1,323)	(1,069)
Total liabilities and stockholders’ deficit	$ 39,909	$ 37,004